Junji Ma

619 total citations
21 papers, 515 citations indexed

About

Junji Ma is a scholar working on Hepatology, Epidemiology and Molecular Biology. According to data from OpenAlex, Junji Ma has authored 21 papers receiving a total of 515 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Hepatology, 12 papers in Epidemiology and 7 papers in Molecular Biology. Recurrent topics in Junji Ma's work include Liver physiology and pathology (11 papers), Liver Disease Diagnosis and Treatment (11 papers) and Cancer Mechanisms and Therapy (4 papers). Junji Ma is often cited by papers focused on Liver physiology and pathology (11 papers), Liver Disease Diagnosis and Treatment (11 papers) and Cancer Mechanisms and Therapy (4 papers). Junji Ma collaborates with scholars based in China and United States. Junji Ma's co-authors include Huiqing Jiang, Yan Wang, Di Zhang, Jian Zhang, Xiaoyu Jiang, Yan Wang, Na Wang, Gai Wang, Fangfang Li and Junli Shi and has published in prestigious journals such as Journal of Hepatology, Experimental Cell Research and World Journal of Gastroenterology.

In The Last Decade

Junji Ma

20 papers receiving 508 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Junji Ma China 11 250 224 188 80 66 21 515
Hsiao‐Yen Ma United States 14 167 0.7× 218 1.0× 212 1.1× 89 1.1× 31 0.5× 18 583
Bert Van Den Bossche Belgium 5 201 0.8× 266 1.2× 133 0.7× 93 1.2× 26 0.4× 10 470
Zoe Boyer‐Díaz Spain 7 218 0.9× 287 1.3× 109 0.6× 84 1.1× 35 0.5× 10 426
Jesús García‐Bañuelos Mexico 14 106 0.4× 175 0.8× 157 0.8× 70 0.9× 59 0.9× 28 544
Maria Ruart Spain 7 189 0.8× 258 1.2× 124 0.7× 81 1.0× 22 0.3× 9 478
Rania Dayoub Germany 13 174 0.7× 189 0.8× 190 1.0× 142 1.8× 17 0.3× 24 467
Yasutoshi Nozaki Japan 8 106 0.4× 317 1.4× 167 0.9× 65 0.8× 48 0.7× 15 535
Derrick Zhao United States 11 163 0.7× 350 1.6× 379 2.0× 99 1.2× 80 1.2× 21 727
Xuguang Zhai China 12 139 0.6× 203 0.9× 162 0.9× 59 0.7× 16 0.2× 25 405

Countries citing papers authored by Junji Ma

Since Specialization
Citations

This map shows the geographic impact of Junji Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junji Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junji Ma more than expected).

Fields of papers citing papers by Junji Ma

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Junji Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junji Ma. The network helps show where Junji Ma may publish in the future.

Co-authorship network of co-authors of Junji Ma

This figure shows the co-authorship network connecting the top 25 collaborators of Junji Ma. A scholar is included among the top collaborators of Junji Ma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Junji Ma. Junji Ma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Xianrui, Zhimin Wang, Lin Zheng, et al.. (2025). Effect of rapamycin nanoparticles in an animal model of primary biliary cholangitis. World Journal of Hepatology. 17(6). 104073–104073.
2.
Lin, Zheng, Ziliang Ye, & Junji Ma. (2024). Effect of cholesterol metabolism on hepatolithiasis. World Journal of Gastroenterology. 31(1). 99960–99960. 3 indexed citations
3.
Xie, Xiao‐Li, Wei Qi, Junji Ma, et al.. (2020). TGR5 promotes cholangiocarcinoma by interacting with mortalin. Experimental Cell Research. 389(2). 111855–111855. 16 indexed citations
4.
Ma, Junji, et al.. (2019). Locostatin Alleviates Liver Fibrosis Induced by Carbon Tetrachloride in Mice. Digestive Diseases and Sciences. 64(9). 2570–2580. 9 indexed citations
5.
Ma, Ning, Xiaolin Zhang, Mingbang Wang, et al.. (2017). Comprehensive investigating of cytokine and receptor related genes variants in patients with chronic hepatitis B virus infection. Cytokine. 103. 10–14. 3 indexed citations
6.
Ding, Qian, Lei Chen, Jia Wang, et al.. (2017). Overexpression of Heparin-Binding Epidermal Growth Factor-Like Growth Factor Mediates Liver Fibrosis in Transgenic Mice. The American Journal of the Medical Sciences. 354(2). 199–210. 8 indexed citations
7.
Zhang, Xiaolin, Ning Ma, Mingbang Wang, et al.. (2017). Comprehensive investigation of cytokine- and immune-related gene variants in HBV-associated hepatocellular carcinoma patients. Bioscience Reports. 37(6). 10 indexed citations
8.
Wang, Yan, Junji Ma, Lei Chen, Xiao‐Li Xie, & Huiqing Jiang. (2016). Inhibition of Focal Adhesion Kinase on Hepatic Stellate-cell Adhesion and Migration. The American Journal of the Medical Sciences. 353(1). 41–48. 13 indexed citations
9.
Chen, Lei, Junji Ma, Di Zhang, et al.. (2016). Knockdown of Astrocyte Elevated Gene-1 Inhibits Activation of Hepatic Stellate Cells. Digestive Diseases and Sciences. 61(7). 1961–1971. 7 indexed citations
10.
Zhang, Di, Junli Shi, Yan Wang, et al.. (2015). Sorafenib induces autophagic cell death and apoptosis in hepatic stellate cell through the JNK and Akt signaling pathways. Anti-Cancer Drugs. 27(3). 192–203. 37 indexed citations
11.
12.
Dai, Erhei, Jian Zhang, Di Zhang, et al.. (2014). Rimonabant inhibits proliferation, collagen secretion and induces apoptosis in hepatic stellate cells.. PubMed. 61(135). 2052–61. 9 indexed citations
13.
Zhao, Dan, Junji Ma, Junli Shi, et al.. (2013). Raf kinase inhibitor protein inhibits esophageal cancer cell invasion through downregulation of matrix metalloproteinase expression. Oncology Reports. 30(1). 304–312. 13 indexed citations
14.
Wang, Yanping, Yuan Shang, Junji Ma, et al.. (2013). Association between gene polymorphisms of IL-28 and response to lamivudine in Chinese rural patients with chronic hepatitis B. Scandinavian Journal of Gastroenterology. 48(6). 745–751. 5 indexed citations
15.
Zhang, Di, Jian Zhang, Xiaoyu Jiang, et al.. (2013). Heparin‐binding epidermal growth factor‐like growth factor: A hepatic stellate cell proliferation inducer via ErbB receptors. Journal of Gastroenterology and Hepatology. 29(3). 623–632. 12 indexed citations
16.
Wang, Na, Gai Wang, Junji Ma, et al.. (2012). Curcumin Ameliorates Hydrogen Peroxide-Induced Epithelial Barrier Disruption by Upregulating Heme Oxygenase-1 Expression in Human Intestinal Epithelial Cells. Digestive Diseases and Sciences. 57(7). 1792–1801. 76 indexed citations
17.
Wang, Yan, et al.. (2010). New insights into the antifibrotic effects of sorafenib on hepatic stellate cells and liver fibrosis. Journal of Hepatology. 53(1). 132–144. 205 indexed citations
18.
Wang, Na, Huiling Yu, Junji Ma, et al.. (2010). Evidence for tight junction protein disruption in intestinal mucosa of malignant obstructive jaundice patients. Scandinavian Journal of Gastroenterology. 45(2). 191–199. 19 indexed citations
19.
Zhang, Sui, et al.. (2010). Short interfering RNA targetting NF-kappa B induces apoptosis of hepatic stellate cells and attenuates extracellular matrix production. Digestive and Liver Disease. 42(11). 813–817. 8 indexed citations
20.
Ma, Junji, Fangfang Li, Li Liu, et al.. (2009). Raf kinase inhibitor protein inhibits cell proliferation but promotes cell migration in rat hepatic stellate cells. Liver International. 29(4). 567–574. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hsiao‐Yen Ma Breakdown of academic impact, for papers by Bert Van Den Bossche Breakdown of academic impact, for papers by Zoe Boyer‐Díaz Breakdown of academic impact, for papers by Jesús García‐Bañuelos Breakdown of academic impact, for papers by Maria Ruart Breakdown of academic impact, for papers by Rania Dayoub Breakdown of academic impact, for papers by Yasutoshi Nozaki Breakdown of academic impact, for papers by Derrick Zhao Breakdown of academic impact, for papers by Xuguang Zhai
Rankless by CCL
2026